Annual Report 2014-2015 of Sun Pharmaceutical Industries Limited

It is a broadly described annual report of Sun Pharmaceutical Industries Limited in the year of 2014-2015. During the financial year, The Company’s Total Revenue Rs. 82,287.7 million. Net Profit after Tax for the year Rs. 14,741.3 million. The dividend on Equity shares Rs. 7,219.5. Book value per equity share of Rs.1/- each Rs. 95/-. The Authorized Share Capital of the Company has increased to 5,990,000,000 Equity Shares of Rs. 1/- each amounting to Rs. 5,990,000,000/- and 100,000 Preference Shares of face value of Rs. 100/- each amounting to 10,000,000/- aggregating to Rs. 6,000,000,000/-.

The Board of Directors is pleased to recommend an equity dividend of Rs. 3.00 per equity share of face value Rs. 1 each (previous year Rs. 1.50 per equity share) for the year ended 31^st March 2015.

More Annual Report of Sun Pharmaceutical Industries Limited: